A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Enniatin complex | A complex of depsipeptides produced by several fusarium species. the complex contains 4 major components: A, A1, B and B1 together with minor amounts of enniatins C, D, E and F. Synonyms: cyclo[N-methyl-L-isoleucyl-N-oxa-D-valyl-N-methyl-L-isoleucyl-N-oxa-D-valyl-N-methyl-L-isoleucyl-N-oxa-D-valyl] compound with cyclo[N-methyl-L-isoleucyl-N-oxa-D-valyl-N-methyl-L-isoleucyl-N-oxa-D-valyl-N-methyl-L-valyl-N-oxa-L-valyl] compound with cyclo[N-methyl-L-isoleucyl-N-oxa-D-valyl-N-methyl-L-valyl-N-oxa-D-valyl-N-methyl-L-valyl-N-oxa-D-valyl] compound with cyclo[N-oxa-D-valyl-N-methyl-L-valyl-N-oxa-D-valyl-N-methyl-L-valyl-N-oxa-D-valyl-N-methyl-L-valyl]. Grades: >95% by HPLC. CAS No. 11113-62-5. Molecular formula: C36H63N3O9. C35H61N3O9. C34H59N3O9. C33H57N3O9. Mole weight: 2643.46. |  |
| Enniatin complex | Enniatins are a complex of depsipeptides produced by several Fusarium species. Typically, the complex contains 4 major components: A, A1, B and B1 together with minor amounts of enniatin C, D, E and F. The enniatins have been shown to act as ionophores. Recently, their effects on acyl-CoA cholesterol transferase, as nematocides and the selectivity of their antitumor action have received more focus. Group: Biochemicals. Grades: Highly Purified. CAS No. 11113-62-5. Pack Sizes: 10mg. US Biological Life Sciences. |  Worldwide |
| Enniatin F | It is produced by the strain of Fusarium orthoceras var. enniatinum. It has insecticidal and antifungal activity, and it also can inhibit Acylcoa, cholesterol acyltransferase (ACAT). Synonyms: Enniatin A, 2-(N-methyl-L-leucine)-; Cyclo(hiv-Me-leu-hiv-Me-ile-hiv-Me-ile). CAS No. 144446-20-8. Molecular formula: C36H63N3O9. Mole weight: 681.90. | |
| Enoblituzumab | Enoblituzumab (MGA271) is a humanized IgG1κ monoclonal antibody recognizing human B7-H3 protein, a member of the B7 family of immune regulators [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MGA271. CAS No. 1353485-38-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9966. |  |
| Enocitabine | Enocitabine. Group: Biochemicals. Grades: Highly Purified. CAS No. 55726-47-1. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C31H55N3O6. US Biological Life Sciences. | Worldwide |
| Enocitabine (N- (1-B-D-Arabinofuranosyl-1, 2-dihydro-2-oxo-4-pyrimidinyl) docosanamide, Behenoylcytosine Arabinoside, BH-AC, NSC-239336, Sunrabin) | An antineoplastic. A derivative of Cytarabine. Group: Biochemicals. Alternative Names: N- (1-B-D-Arabinofuranosyl-1, 2-dihydro-2-oxo-4-pyrimidinyl) docosanamide, Behenoylcytosine Arabinoside, BH-AC, NSC-239336, Sunrabin. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Enocyanin | Enocyanin. Synonyms: GRAPE SKIN EXTRACT 30% POLYPHENOLS;Anthocyanins, grape; BLUEBERRYANTHOCYANINS; GRAPEJUICECOLOUR; HIBISCUSSABDARIFFAL.ANTHOCYANINS; GRAPESKINCOLOUR; PURPLECORNCOLOUR; TAMARINDCOLOUR. CAS No. 11029-12-2. Pack Sizes: 1 kg. Product ID: CDF4-0026. Molecular formula: C15H11O+. Category: Color Fixative. Product Keywords: Food Ingredients; Color Fixative; Enocyanin; CDF4-0026; 11029-12-2; C15H11O+; 11029-12-2. Purity: 0.99. Color: Very Dark Purple to Black. Physical State: Solid. Solubility: DMF (Slightly), DMSO (Slightly), Methanol (Slightly). Storage: -20°C. |  |
| Enocyanin | Heterocyclic Organic Compound. Alternative Names: ANTHOCYANINS;GRAPE SKIN EXTRACT 30% POLYPHENOLS;Anthocyanins, grape; BLUEBERRYANTHOCYANINS; GRAPEJUICECOLOUR; HIBISCUSSABDARIFFAL.ANTHOCYANINS; GRAPESKINCOLOUR; PURPLECORNCOLOUR. CAS No. 11029-12-2. Molecular formula: C27H31O16. Mole weight: 207.247240 [g/mol]. Appearance: Violet-red fine powder. Purity: 0.96. IUPACName: 2-phenylchromenylium. Density: g/cm³. Catalog: ACM11029122. |  |
| Enokizumab | Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MEDI-528. CAS No. 909875-08-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99193. | |
| Enokizumab | Enokizumab is a monoclonal antibody targeting interleukin-9. Synonyms: MEDI-528; MEDI 528; MEDI528. CAS No. 909875-08-7. | |
| Enopeptin A | It is produced by the strain of Streptomyces griseus. It has activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and it also has antibacterial activity of phage. Synonyms: N-[[(2E,4E,6E,8E,10E)-12-(2-Hydroxy-5-oxo-1-cyclopentenylamino)-1,12-dioxo-2,4,6,8,10-dodecapentenyl]-L-Phe-]cyclo[L-Ser*-L-Pro-N-methyl-L-Ala-L-Ala-4β-methyl-L-Pro-]; [trans-(all-E)]-1-[N-[N-[1-[N-[N-[12-[(2-Hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-1,12-dioxo-2,4,6,8,10-dodecapentaenyl]-L-phenylalanyl]-L-seryl]-L-prolyl]-N-methyl-L-alanyl]-L-alanyl]-4-methyl-L-proline ξ-lactone; Enopeptin II; NSC657143. Grades: >95% by HPLC. CAS No. 139601-96-0. Molecular formula: C47H57N7O11. Mole weight: 896.00. | |
| Enoticumab | Enoticumab (REGN421, SAR153192) is an IgG1κ antibody targeting human Dll4. DLL4 is a ligand of the Notch signaling pathway and regulates fatty acid uptake through non-transcriptional regulation of macropinocytosis-dependent long-chain fatty acid uptake. Specific in vivo activity of Enoticumab in an ovarian xenograft model. EGN421 (2.5 mg/kg once weekly) resulted in 86% and 83% tumor growth inhibition in mouse subcutaneous TOV-112D or intraperitoneal A2780 human tumor xenograft models, respectively [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: REGN421. CAS No. 1192578-27-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99925. | |
| Enoxacin | 1g Pack Size. Group: Antibiotics, Bioactive Small Molecules. Formula: C15H17FN4O3. CAS No. 74011-58-8. Prepack ID 71188914-1g. Molecular Weight 320.32. See USA prepack pricing. |  |
| Enoxacin | A fluororquinolone antibacterial used to treat urinary tract infections and gonorrhea. Group: Biochemicals. Alternative Names: 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic Acid; Enofloxacin; Enofloxacine; Enoksetin; Flumark; NSC 629661; PD 107779; Penetrex. Grades: Highly Purified. CAS No. 74011-58-8. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Enoxacin | Enoxacin is an oral broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections and gonorrhea. Insomnia is a common adverse effect. Uses: Anti-bacterial agents. Synonyms: R41468; R41468; R-41468; PD 107779; PD-107779; PD107779; Penetrex; Enoxacine; Comprecin. Grades: >98%. CAS No. 74011-58-8. Molecular formula: C15H17FN4O3. Mole weight: 320.32. | |
| Enoxacin glyconate | Heterocyclic Organic Compound. Alternative Names: ENOXACIN GLUCONATE;ENOXACIN GLYCONATE. CAS No. 104142-71-4. Molecular formula: C15H17FN4O3.C6H12O7. Mole weight: 534.491. Catalog: ACM104142714. | |
| Enoxacin hydrate | Enoxacin hydrate (Enoxacin sesquihydrate), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC 50 =126 μg/ml) and topoisomerase IV (IC 50 =26.5 μg/ml). Enoxacin hydrate is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin hydrate has potent activities against gram-positive and -negative bacteria. Enoxacin hydrate is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing [1] [2] [3] [4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Enoxacin sesquihydrate; AT-2266 hydrate; CI-919 hydrate. CAS No. 84294-96-2. Pack Sizes: 100 mg; 500 mg. Product ID: HY-B0268A. | |
| Enoxacin hydrate | Enoxacin hydrate is a synthetic antibiotic belonging to quinolone carboxylic acid compound. It is bactericidal and has a postantibiotischen effect. It is a broad-spectrum antibacterial agent and inhibited 90% Escherichia coli, Klebsiella sp., Aeromonas sp., Enterobacter spp., Serratia spp., Proteus mirabilis, and Morganella morganii at less than or equal to 0.8 micrograms/ml. Uses: Enoxacin hydrate is bactericidal and has a postantibiotischen effect. it is a broad-spectrum antibacterial agent. Synonyms: Enoxacin sesquihydrate;AT-2266 hydrate;CI-919 hydrate; AT 2266 hydrate;CI 919 hydrate; AT2266 hydrate;CI919 hydrate; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic Acid hydrate. Grades: >98%. CAS No. 84294-96-2. Molecular formula: C30H40F2N8O9. Mole weight: 694.694. | |
| Enoxacin Sesquihydrate | Enoxacin Sesquihydrate. Group: Biochemicals. Alternative Names: 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic Acid Sesquihydrate. Grades: Highly Purified. CAS No. 84294-96-2. Pack Sizes: 5g, 10g, 25g, 50g, 100g. US Biological Life Sciences. | Worldwide |
| Enoxaparin | Enoxaparin (PK 10169), a low-molecular-weight heparin (LMWH) derivative. Enoxaparin exerts anticoagulant activity through antithrombin III, an endogenous inhibitor of factor Xa and thrombin IIa. Enoxaparin protect the rat hippocampus against TBI (traumatic brain injury) via antioxidant and anti-inflammatory properties. Enoxaparin can be used for the research of deep vein thrombosis (DVT), pulmonary embolism, TBI and COVID-19 [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PK 10169; Enoxaparin sodium. CAS No. 679809-58-6. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-109509. | |
| Enoxaparin sodium | Cas No. 679809-58-6. | |
| Enoxaparin Sodium | Enoxaparin sodium consists of a complex set of oligosaccharides that have not yet been fully characterized. Most of the components have a 4-chenuronic acid structure at the non-reducing end of their chains. About 20% of the materials containing Chemicalbook have 1, 6-dehydrated derivatives at the reduced end of the chain, ranging between 15% and 25%. The weight average molecular weight of sodium Enox-aparin is 4500Da and ranges from 3800 to 5000Da. Synonyms: ENOXAPARIN SODIUM, EP STANDARD;Lovenox;Lovenox (preservative free); Unii-8nz41mik1o; Clexane; Enoxil; Klexane; Enoxaparin SodiuM EP. CAS No. 679809-58-6. Product ID: PAP-0073. Molecular formula: C57H82N4Na4O53S3. Category: Cardiovascular. Product Keywords: Cardiovascular Series; Enoxaparin Sodium; PAP-0073; Cardiovascular; C57H82N4Na4O53S3; 679809-58-6. Appearance: White to Off-White. Standard: CP/EP/USP. Chemical Name: ENOXAPARIN SODIUM, EP STANDARD;Lovenox;Lovenox (preservative free); Unii-8nz41mik1o; Clexane; Enoxil; Klexane; Enoxaparin SodiuM EP. Grade: Pharmaceutical Grade. Solubility: Water (Slightly). Storage: Room Temperature, Under inert atmosphere. Product Description: Enoxaparin sodium consists of a complex set of oligosaccharides that have not yet been fully characterized. Most of the components have a 4-chenuronic acid structure at the non-reducing end of their chains. About 20% of the materials containing Chemicalbook have 1, 6-dehydrated derivatives at t | |
| Enoxaparin Sodium | Enoxaparin Sodium. Group: Biochemicals. Alternative Names: Heparin sodium salt. Grades: Purified. CAS No. 679809-58-6. Pack Sizes: 100mg, 250mg, 500mg, 1g. Molecular Formula: (C25H40N2O36S5)n Polymer, Molecular Weight (ave): 3500-5500. US Biological Life Sciences. | Worldwide |
| Enoxastrobin | Enoxastrobin is a fungicide. Group: Biochemicals. Grades: Highly Purified. CAS No. 238410-11-2. Pack Sizes: 10mg, 25mg. Molecular Formula: C22H22ClNO4, Molecular Weight: 399.87. US Biological Life Sciences. | Worldwide |
| Enoximone | Enoximone. Group: Biochemicals. Grades: Purified. CAS No. 77671-31-9. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Enoximone | Enoximone is a selective phosphodiesterase III (PDE3) inhibitor. It can be used for the treatment of heart failure. Uses: Heart failure. Synonyms: Enoximone; Perfan; Fenoximone; MDL-17043; Enoximonum [Latin]; MDL 19438; MDL-17,043; MDL-17043; MDL-19,438; MDL17,043; MDL17043; MDL19,438; Myogen Brand of Enoximone; Perfan; 1,3-Dihydro-4-methyl-5-[4-(methylthio)benzoyl]-2H-imidazol-2-one; Fenoximone; MDL 17043; Perfan; Perfane; RMI 17043. Grades: 98%. CAS No. 77671-31-9. Molecular formula: C12H12N2O2S. Mole weight: 248.3. | |
| Enoximone | Enoximone is an inotropic vasodilating agent and a selective and orally active phosphodiesterase III (PDE3) inhibitor with an IC 50 of 5.9 μM. Enoximone induces vasodilatation and increases intracellular levels of cAMP by inhibiting cGMP-inhibited PDE. Enoximone also exhibits PDE4 inhibitory effect with an IC 50 of 21.1 μM for myocardial PDE4A. Enoximone has the potential for congestive heart failure research and has bronchodilatory, antiasthma and anti-inflammatory effects [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 77671-31-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg. Product ID: HY-B1639. | |
| enoyl-[acyl-carrier-protein] reductase (NADH) | The enzyme catalyses an essential step in fatty acid biosynthesis, the reduction of the 2,3-double bond in enoyl-acyl-[acyl-carrier-protein] derivatives of the elongating fatty acid moiety. The enzyme from the bacterium Escherichia coli accepts substrates with carbon chain length from 4 to 18. The enzyme from the bacterium Mycobacterium tuberculosis prefers substrates with carbon chain length from 12 to 24 carbons. Group: Enzymes. Synonyms: enoyl-[acyl carrier protein] reductase; enoyl-ACP reductase; NADH-enoyl acyl carrier protein reductase; NADH-specific enoyl-ACP reductase; acyl-[acyl-carrier-protein]:NAD+ oxidoreductase; fabI (gene name); inhA (gene name). Enzyme Commission Number: EC 1.3.1.9. CAS No. 37251-08-4. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-1359; enoyl-[acyl-carrier-protein] reductase (NADH); EC 1.3.1.9; 37251-08-4; enoyl-[acyl carrier protein] reductase; enoyl-ACP reductase; NADH-enoyl acyl carrier protein reductase; NADH-specific enoyl-ACP reductase; acyl-[acyl-carrier-protein]:NAD+ oxidoreductase; fabI (gene name); inhA (gene name). Cat No: EXWM-1359. |  |
| enoyl-[acyl-carrier-protein] reductase (NADPH) | The enzyme completes each cycle of fatty acid elongation by catalysing the stereospecific reduction of the double bond at position 2 of a growing fatty acid chain, while linked to the acyl-carrier protein, in an NADPH-dependent manner. This entry stands for enzymes whose stereo-specificity with respect to NADP+ is not known. [cf. EC 1.3.1.39 enoyl-[acyl-carrier-protein] reductase (NADPH, Re-specific), EC 1.3.1.10, enoyl-[acyl-carrier-protein] reductase (NADPH, Si-specific) and EC 1.3.1.9, enoyl-[acyl-carrier-protein] reductase (NADH)]. Group: Enzymes. Synonyms: acyl-ACP dehydrogenase (ambiguous); enoyl-[acyl carrier protein] (reduced nicotinamide adenine dinucleotide phosphate) reductase; NADPH 2-enoyl Co A reductase; enoyl-ACP reductase (ambiguous); fabL (gene name). Enzyme Commission Number: EC 1.3.1.104. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-1276; enoyl-[acyl-carrier-protein] reductase (NADPH); EC 1.3.1.104; acyl-ACP dehydrogenase (ambiguous); enoyl-[acyl carrier protein] (reduced nicotinamide adenine dinucleotide phosphate) reductase; NADPH 2-enoyl Co A reductase; enoyl-ACP reductase (ambiguous); fabL (gene name). Cat No: EXWM-1276. | |
| enoyl-[acyl-carrier-protein] reductase (NADPH, Re-specific) | This enzyme completes each cycle of fatty acid elongation by catalysing the stereospecific reduction of the double bond at position 2 of a growing fatty acid chain, while linked to an acyl-carrier protein. It is one of the activities of EC 2.3.1.85, animal fatty-acid synthase. The mammalian enzyme is Re-specific with respect to NADP+. cf. EC 1.3.1.10, enoyl-[acyl-carrier-protein] reductase (NADPH, Si-specific) and EC 1.3.1.104, enoyl-[acyl-carrier-protein] reductase (NADPH). Group: Enzymes. Synonyms: acyl-ACP dehydrogenase; enoyl-[acyl carrier protein] (reduced nicotinamide adenine dinucleotide phosphate) reductase; NADPH 2-enoyl Co A reductase. Enzyme Commission Number: EC 1.3.1.39. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-1311; enoyl-[acyl-carrier-protein] reductase (NADPH, Re-specific); EC 1.3.1.39; acyl-ACP dehydrogenase; enoyl-[acyl carrier protein] (reduced nicotinamide adenine dinucleotide phosphate) reductase; NADPH 2-enoyl Co A reductase; enoyl-ACp reductase; enoyl-[acyl-carrier-protein] reductase (NADPH2, A-specific); acyl-[acyl-carrier-protein]:NADP+ oxidoreductase (A-specific); enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific); acyl-[acyl-carrier protein]:NADP+ oxidoreductase (A-specific). Cat No: EXWM-1311. | |
| enoyl-[acyl-carrier-protein] reductase (NADPH, Si-specific) | One of the activities of EC 2.3.1.86, fatty-acyl-CoA synthase, an enzyme found in yeasts (Ascomycota and the Basidiomycota). Catalyses the reduction of enoyl-acyl-[acyl-carrier protein] derivatives of carbon chain length from 4 to 16. The yeast enzyme is Si-specific with respect to NADP+. cf. EC 1.3.1.39, enoyl-[acyl-carrier-protein] reductase (NADPH, Re-specific) and EC 1.3.1.104, enoyl-[acyl-carrier-protein] reductase (NADPH), which describes enzymes whose stereo-specificity towards NADPH is not known. See also EC 1.3.1.9, enoyl-[acyl-carrier-protein] reductase (NADH). Group: Enzymes. Synonyms: acy. Enzyme Commission Number: EC 1.3.1.10. CAS No. 37251-09-5. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-1271; enoyl-[acyl-carrier-protein] reductase (NADPH, Si-specific); EC 1.3.1.10; 37251-09-5; acyl-ACP dehydrogenase (ambiguous); enoyl-[acyl carrier protein] (reduced nicotinamide adenine dinucleotide phosphate) reductase; NADPH 2-enoyl Co A reductase; enoyl acyl-carrier-protein reductase (ambiguous); enoyl-ACP reductase (ambiguous); acyl-[acyl-carrier-protein]:NADP+ oxidoreductase (B-specific); acyl-[acyl-carrier protein]:NADP+ oxidoreductase (B-specific); enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific). Cat No: EXWM-1271. | |
| enoyl-CoA hydratase | Acts in the reverse direction. With cis-compounds, yields (3R)-3-hydroxyacyl-CoA. cf. EC 4.2.1.74 long-chain-enoyl-CoA hydratase. Group: Enzymes. Synonyms: enoyl hydrase; unsaturated acyl-CoA hydratase; β-hydroxyacyl-CoA dehydrase; β-hydroxyacid dehydrase; acyl coenzyme A hydrase; crotonase; crotonyl hydrase; 2-octenoyl coenzyme A hydrase; enoyl coenzyme A hydratase; 2-enoyl-CoA hydratase; short-chain enoyl-CoA hydratase; ECH; trans-2-enoyl-CoA hydratase; enoyl coenzyme A hydrase (D); enoyl coenzyme A hydrase (L); short chain enoyl coenzyme A hydratase; D-3-hydroxyacyl-CoA dehydratase; enol-CoA hydratase. Enzyme Commission Number: EC 4.2.1.17. CAS No. 9027-13-8. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5010; enoyl-CoA hydratase; EC 4.2.1.17; 9027-13-8; enoyl hydrase; unsaturated acyl-CoA hydratase; β-hydroxyacyl-CoA dehydrase; β-hydroxyacid dehydrase; acyl coenzyme A hydrase; crotonase; crotonyl hydrase; 2-octenoyl coenzyme A hydrase; enoyl coenzyme A hydratase; 2-enoyl-CoA hydratase; short-chain enoyl-CoA hydratase; ECH; trans-2-enoyl-CoA hydratase; enoyl coenzyme A hydrase (D); enoyl coenzyme A hydrase (L); short chain enoyl coenzyme A hydratase; D-3-hydroxyacyl-CoA dehydratase; enol-CoA hydratase. Cat No: EXWM-5010. | |
| enoyl-CoA hydratase 2 | This enzyme catalyses a hydration step in peroxisomal β-oxidation. The human multifunctional enzyme type 2 (MFE-2) is a 79000 Da enzyme composed of three functional units: (3R)-hydroxyacyl-CoA dehydrogenase, 2-enoyl-CoA hydratase 2 and sterol carrier protein 2-like units. The enzymes from Aeromonas caviae and Arabidopsis thaliana are monofunctional enzymes. 2-Enoyl-CoA hydratase 3 from Candida tropicalis is a part from multifunctional enzyme type 2. Group: Enzymes. Synonyms: 2-enoyl-CoA hydratase 2; AtECH2; ECH2; MaoC; MFE-2; PhaJAc; D-3-hydroxyacyl-CoA hydro-lyase; D-specific 2-trans-enoyl-CoA hydratase. Enzyme Commission Number: EC 4.2.1.119. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4959; enoyl-CoA hydratase 2; EC 4.2.1.119; 2-enoyl-CoA hydratase 2; AtECH2; ECH2; MaoC; MFE-2; PhaJAc; D-3-hydroxyacyl-CoA hydro-lyase; D-specific 2-trans-enoyl-CoA hydratase. Cat No: EXWM-4959. | |
| Enpatoran free base | Enpatoran, also known as M5049, is a novel selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity. M5049 was found to be potent in vivo as TLR7/8 inhibition efficaciously treated disease in several murine lupus models and, interestingly, was efficacious in a disease context in which TLR7/8 activity has not previously been considered a primary disease driver. Furthermore, M5049 had greater potency in disease models than expected based on its in vitro potency and pharmacokinetic/pharmacodynamic properties. Group: Inhibitors. Alternative Names: Enpatoran; M 5049; M5049; M-5049. CAS No. 2101938-42-3. Molecular formula: C16H15F3N4. Mole weight: 320.32. Appearance: Solid powder. Purity: >98%. IUPACName: 5-((3R,5S)-3-amino-5-(trifluoromethyl)piperidin-1-yl)quinoline-8-carbonitrile. Canonical SMILES: N[C@]1 ([H])C[C@] ([H]) (C (F) (F)F)CN (C2=CC=C (C#N)C3=C2C=CC=N3)C1. Catalog: ACM2101938423. | |
| Enprofylline | Enprofylline, a xanthine derivative, is a a competitive nonselective phosphodiesterase inhibitor with relatively little activity as a nonselective adenosine receptor antagonist used in the treatment of asthma, which acts as a bronchodilator. Uses: Nonselective adenosine receptor antagonist. Synonyms: 3-Propylxanthine; 3-propyl-7H-purine-2,6-dione. Grades: ≥98%. CAS No. 41078-02-8. Molecular formula: C8H10N4O2. Mole weight: 194.19. | |
| Enprofylline | Enprofylline acts as a selective and competitive A2B receptor antagonist with the K i of 7 μM. Enprofylline also acts as a phosphodiesterase inhibitor. Enprofylline can be used for the research of asthma, chronic obstructive pulmonary disease [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 41078-02-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg. Product ID: HY-14117. | |
| Enrasentan | Enrasentan, an indene derivative, has been found to be an endothelin receptor antagonist that was once studied in reperfusion injury and heart failure therapy. Synonyms: Enrasentan; SB-217242; UNII-QG16H8A6ZH; SB 217242; SB217242; CHEMBL431651; (1S,2R,3S)-1-(1,3-benzodioxol-5-yl)-3-[2-(2-hydroxyethoxy)-4-methoxyphenyl]-5-propoxy-2,3-dihydro-1H-indene-2-carboxylic acid. Grades: 98%. CAS No. 167256-08-8. Molecular formula: C29H30O8. Mole weight: 506.55. | |
| Enrofloxacin | Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC 90 of 0.312 μg/mL for Mycoplasma bovis. Uses: Scientific research. Group: Natural products. Alternative Names: BAY Vp 2674; PD160788. CAS No. 93106-60-6. Pack Sizes: 10 mM * 1 mL; 500 mg; 5 g; 10 g. Product ID: HY-B0502. | |
| Enrofloxacin | Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC90 of 0.312 μg/mL forMycoplasma bovis. Group: Inhibitors. Alternative Names: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-quinoline-3-carboxylic acid; Baytri; Enrofloxacin; ROFLOXACIN BASE; Enrofoxacin; Enrolfoxacin; bayvp2674; 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethylpiperazino)-quinoline-3-carboxylic acid; 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-7-(4-ethyl-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid; Enorfloxacin; cfpq. CAS No. 93106-60-6. Molecular formula: C19H22FN3O3. Mole weight: 359.39. Appearance: Pale Yellow Crystals. Purity: 95%+. IUPACName: 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylicacid. Canonical SMILES: CCN1CCN (CC1)C2=C (C=C3C (=C2)N (C=C (C3=O)C (=O)O)C4CC4)F. Density: 1.385g/cm³. ECNumber: 618-911-2. Catalog: ACM93106606. | |
| Enrofloxacin | Fluorinated quinolone antibacterial. Group: Biochemicals. Alternative Names: 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; CFPQ; Bay vp 2674. Grades: Highly Purified. CAS No. 93106-60-6. Pack Sizes: 5g, 10g, 25g, 50g. US Biological Life Sciences. | Worldwide |
| Enrofloxacin | 5g Pack Size. Group: Antibiotics, Bioactive Small Molecules. Formula: C19H22FN3O3. CAS No. 93106-60-6. Prepack ID 57134695-5g. Molecular Weight 359.39. See USA prepack pricing. | |
| Enrofloxacin Base | Enrofloxacin Base. Categories: enrofloxacin; 93106-60-6. |  CA, FL & NJ |
| Enrofloxacin-d5 | Heterocyclic Organic Compound. Alternative Names: 1-Cyclopropyl-7-[4-(ethyl-d5)-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo- 3-quinolinecarboxylic Acid; CFPQ-d5; Bay Vp 2674-d5; Baytril-d5. CAS No. 1173021-92-5. Molecular formula: C19H17D5FN3O3. Mole weight: 364.43. Appearance: Tan Solid. Purity: 0.96. IUPACName: 1-cyclopropyl-6-fluoro-4-oxo-7-[4-(1,1,2,2,2-pentadeuterioethyl)piperazin-1-yl]quinoline-3-carboxylic acid. Canonical SMILES: CCN1CCN (CC1)C2=C (C=C3C (=C2)N (C=C (C3=O)C (=O)O)C4CC4)F. Catalog: ACM1173021925. | |
| Enrofloxacin-d5 | Labeled fluorinated quinolone antibacterial. Group: Biochemicals. Alternative Names: 1-Cyclopropyl-7-[4-(ethyl-d5)-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; CFPQ-d5; Bay Vp 2674-d5; Baytril-d5. Grades: Highly Purified. CAS No. 1173021-92-5. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Enrofloxacin-d5 | Enrofloxacin-d 5 is the deuterium labeled Enrofloxacin. Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis. Uses: Scientific research. Group: Isotope-labeled compounds. Alternative Names: BAY Vp 2674-d5; PD160788-d5. CAS No. 1173021-92-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-B0502S. | |
| Enrofloxacin-d5hi(ethyl-d5) | Heterocyclic Organic Compound. CAS No. 1219795-24-0. Molecular formula: 492.34. Purity: 99 atom % D. Catalog: ACM1219795240. | |
| Enrofloxacin EP Impurity E | Enrofloxacin EP Impurity E. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 6-chloro-1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. CAS No. 1369495-59-9. Molecular Formula: C19H22ClN3O3. Mole Weight: 375.85. Catalog: APB1369495599. |  |
| Enrofloxacin EP Impurity F | Enrofloxacin EP Impurity F. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoroquinolin-4(1H)-one. CAS No. 131775-99-0. Molecular Formula: C18H22FN3O. Mole Weight: 315.39. Catalog: APB131775990. | |
| Enrofloxacin hydrochloride | Heterocyclic Organic Compound. CAS No. 112732-17-9. Molecular formula: C19H22FN3O3?HCl. Mole weight: 395.86. Density: 1.385g/cm³. Catalog: ACM112732179. | |
| Enrofloxacin hydrochloride | Enrofloxacin hydrochloride is a fluoroquinolone antibiotic commonly used in veterinary medicine. Synonyms: Enrofloxacin HCl. CAS No. 112732-17-9. Molecular formula: C19H22FN3O3.HCl. Mole weight: 395.86. | |
| Enrofloxacin hydrochloride | 1g Pack Size. Group: Antibiotics, Bioactive Small Molecules. Formula: C19H22FN3O3 ¢HCl. CAS No. 112732-17-9. Prepack ID 89967261-1g. Molecular Weight 395.86. See USA prepack pricing. | |
| Enrofloxacin (Standard) | Enrofloxacin (Standard) is the analytical standard of Enrofloxacin. This product is intended for research and analytical applications. Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis. Uses: Scientific research. Group: Natural products. CAS No. 93106-60-6. Pack Sizes: 25 mg; 50 mg; 100 mg; 250 mg. Product ID: HY-B0502R. | |
| Ensartinib | Ensartinib. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 6-amino-5-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-((3S,5R)-3,5-dimethylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide. CAS No. 1370651-20-9. Molecular Formula: C26H27Cl2FN6O3. Mole Weight: 561.44. Catalog: APB1370651209. | |
| Ensartinib | Ensartinib (X-396) is a potent and dual ALK / MET inhibitor with IC 50 s of <0.4 nM and 0.74 nM, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: X-396. CAS No. 1370651-20-9. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-103714. | |
| Ensartinib dihydrochloride | Ensartinib dihydrochloride (X-396 dihydrochloride) is a potent and dual ALK / MET inhibitor with IC 50 s of <0.4 nM and 0.74 nM, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: X-396 dihydrochloride. CAS No. 2137030-98-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-103714A. | |
| Ensemble Compound 159 | Ensemble Compound 159 is a peptide inhibitor of IL-17A that binds to IL-17A and/or inhibits formation of the IL-17A-IL-17RA complex via an ELISA assay, an HT29-GROα cell based functional assay, a rheumatoid arthritis synovial fibroblast (RASF) assay, and surface plasmon resonance (SPR, Kd < 100 nM) based biophysical binding assessment. Grades: 97%. CAS No. 1449208-36-9. Molecular formula: C42H51ClN6O6. Mole weight: 771.34. | |
| Ensifentrine | Ensifentrine (RPL-554) is an inhaled first-in-class dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 with IC 50 s of 0.4 nM and 1479 nM, respectively. Ensifentrine has bronchoprotective and anti-inflammatory activities. Ensifentrine can be used for chronic obstructive pulmonary disease (COPD) research [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: RPL-554. CAS No. 1884461-72-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-119708. | |
| Ensitrelvir | Ensitrelvir (S-217622) is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor ( IC 50 =13 nM) [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: S-217622. CAS No. 2647530-73-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-143216. | |
| Ensitrelvir | Ensitrelvir (S-217622) is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM). Group: Inhibitors. Alternative Names: 6-[(6-Chloro-2-methylindazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione. CAS No. 2647530-73-0. Molecular formula: C22H17ClF3N9O2. Mole weight: 531.88. Appearance: Solid. Purity: 0.98. IUPACName: 6-[(6-chloro-2-methylindazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione. Canonical SMILES: CN1C=C2C=C (C (=CC2=N1)Cl)NC3=NC (=O)N (C (=O)N3CC4=CC (=C (C=C4F)F)F)CC5=NN (C=N5)C. Catalog: ACM2647530730. | |
| Ensitrelvir fumarate | Ensitrelvir, also known as S-217622, is an antiviral drug developed by Shionogi in partnership with Hokkaido University, which acts as an orally active 3C-like protease inhibitor for the treatment of COVID-19 infection. It is taken by mouth, and has been successfully tested against the recently emerged Omicron variant. It is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM). It became the first Japanese domestic pill to treat COVID-19, third to be regulatorally approved in Japan; in February 2022. Group: Inhibitors. Alternative Names: Ensitrelvir fumarate; S-217622; S 217622; S217622; Xocova. CAS No. 2757470-18-9. Molecular formula: C26H21ClF3N9O6. Mole weight: 647.96. Appearance: Solid powder. Purity: >98%. IUPACName: (E)-6-((6-chloro-2-methyl-2H-indazol-5-yl)imino)-3-((1-methyl-1H-1,2,4-triazol-3-yl)methyl)-1-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4-dione fumaric acid. Canonical SMILES: O=C (N (CC1=NN (C)C=N1)C (N/2)=O)N (CC3=CC (F)=C (F)C=C3F)C2=N\C4=CC5=CN (C)N=C5C=C4Cl. O=C (O)/C=C/C (O)=O. Catalog: ACM2757470189. | |
| Ensitrelvir fumarate | Ensitrelvir (S-217622) fumarate is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor ( IC 50 =13 nM) [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: S-217622 fumarate. CAS No. 2757470-18-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-143216A. | |
| Ensituximab | Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anti-MUC5AC Reference Antibody (ensituximab); NEO-102. CAS No. 1092658-06-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99362. | |
| Ensulizole | Ensulizole is a sulfonated UV absorber and can intense UVB and partial UVA absorption. Ensulizole can damage the DNA through the generation of reactive oxygen species ( ROS ) upon UV or sunlight irradiation [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 27503-81-7. Pack Sizes: 10 mM * 1 mL; 100 mg; 500 mg. Product ID: HY-109654. | |
| Ent-11Beta-Hydroxyatis-16-Ene-3,14-Dione | Terpenoids. CAS No. 1092103-22-4. Molecular formula: C20H28O3. Mole weight: 316.4. Appearance: Powder. Purity: 0.98. IUPACName: (1S, 4S, 9R, 10S, 11R, 12R)-11-hydroxy-5, 5, 9-trimethyl-16-methylidenetetracyclo[10.2.2.01, 10.04, 9]hexadecane-6, 14-dione. Canonical SMILES: CC1 (C2CCC34CC (=C)C (CC3=O)C (C4C2 (CCC1=O)C)O)C. Catalog: ACM1092103224. | |
| Ent-14,16-Epoxy-8-Pimarene-3,15-Diol | Terpenoids. CAS No. 1188281-98-2. Molecular formula: C20H32O3. Mole weight: 320.5. Appearance: Powder. Purity: 0.98. IUPACName: (1R,3aR,5aS,7R,9aR,11aR)-6,6,9a,11a-tetramethyl-2,3a,4,5,5a,7,8,9,10,11-decahydro-1H-naphtho[1,2-g][1]benzofuran-1,7-diol. Canonical SMILES: CC1 (C2CCC3=C (C2 (CCC1O)C)CCC4 (C3OCC4O)C)C. Catalog: ACM1188281982. | |
| Ent-16Alpha,17-Dihydroxyatisan-3-One | Terpenoids. CAS No. 112523-91-8. Molecular formula: C20H32O3. Mole weight: 320.5. Appearance: Powder. Purity: 0.98. Canonical SMILES: CC1 (C2CCC34CCC (CC3C2 (CCC1=O)C)C (C4) (CO)O)C. Catalog: ACM112523918. | |
| ENT 25641 | This active molecular is a bio-active chemical and detailed information has not been published yet. Synonyms: 4-(Aminosulfonyl)phenyl dimethyl phosphate,AC 28,865 AI3-25641; American cyanamid CL-28865; Benzenesulfonamide, p-hydroxy-, dimethyl phosphate; BRN 2148113; CL 28865; BRN2148113; CL28865; BRN-2148113; CL-28865. Grades: 98%. CAS No. 115-92-4. Molecular formula: C8H12NO6PS. Mole weight: 281.22. | |
| ENT 25642 | ENT 25642, a sulfamide derivative, could have potential activities in sorts of biological studies. Synonyms: ENT 25642; ENT25642; ENT-25642; BRN 2168785; CL-35217;AC 35,217; ENT 25,642. Grades: 98%. CAS No. 1713-54-8. Molecular formula: C11H18NO5PS2. Mole weight: 339.37. | |
| ent-9-Desmethyl-alpha-Dihydro-Tetrabenazine | Ent-9-Desmethyl-alpha-Dihydro-Tetrabenazine is one of Tetrabenazine derivatives. Tetrabenazine is a VMAT-inhibitor used for treatment of hyperkinetic movement disorder. It is a monoamine-depleting and a dopamine-receptor-blocking drug and is an effective and safe drug for the treatment of a variety of hyperkinetic movement disorders. Synonyms: (-)-9-O-Desmethyl-alpha-dihydrotetrabenazine; (2S,3R,11bS)-10-Methoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline-2,9-diol; (-)-9-deMe-DTBZ; 3-isobutyl-10-methoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinoline-2,9-diol. Grades: ≥95%. CAS No. 1065193-41-0. Molecular formula: C18H27NO3. Mole weight: 305.41. | |
| ent-Abacavir | The enatiomer of the nucleoside reverse transcriptase inhibitor (NRTI) Abacavir with similar antiviral properties. Group: Biochemicals. Alternative Names: (1R,4S)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol;(1R-cis)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (1R,4S)-Abacavir. Grades: Highly Purified. CAS No. 136470-79-6. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
